The K1 capsular polysaccharide from Acinetobacter baumannii Is a potential therapeutic target via passive immunization

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1128/IAI.01184-12
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: 1; Search for: 1; Search for: 1; Search for: ; Search for: ; Search for:
Affiliation
  1. National Research Council of Canada. NRC Institute for Biological Sciences
FormatText, Article
Subjectepitope; K1 capsular polysaccharide; monoclonal antibody; polysaccharide; unclassified drug; Acinetobacter baumannii; animal experiment; animal model; bacterial capsule; bacterial clearance; bacterial growth; bacterial strain; bacterial survival; bactericidal activity; carbohydrate analysis; immunogenicity; male; mass spectrometry; molecular mimicry; mouse; neutrophil; nuclear magnetic resonance; opsonization; passive immunization; rat; seroprevalence; serotype; soft tissue infection; Acinetobacter baumannii; Acinetobacter Infections; Antibodies, Monoclonal; Bacterial Capsules; Bacterial Vaccines; Epitopes; Flow Cytometry; Gene Expression Regulation, Bacterial; Immunization, Passive; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Rats; Rats, Long-Evans
Abstract
Publication date
In
LanguageEnglish
Peer reviewedYes
NPARC number21269590
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier2736793c-658d-4053-acfa-cbe77b1f59a9
Record created2013-12-13
Record modified2020-04-22
Date modified: